Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes
- PMID: 1569393
- PMCID: PMC2119224
- DOI: 10.1084/jem.175.5.1195
Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes
Abstract
Human activated T lymphocytes expressing class II molecules are able to present only complex antigens that bind to their own surface receptors, and thus can be captured, internalized, and processed through the class II major histocompatibility complex processing pathway. We have used the antigen-presenting T cell system to identify the viral receptor used by hepatitis B virus (HBV) to enter cells, as well as the sequence of HB envelope antigen (HBenvAg) involved in this interaction. Results show that both CD4+ and CD8+ T clones can process and present HBenvAg to class II-restricted cytotoxic T lymphocytes and that the CD71 transferrin receptor (TfR) is involved in efficient HBenvAg uptake by T cells. Moreover, we provide evidence that the HBenvAg sequence interacting with the T cell surface is contained within the pre-S2 region. Since TfR is also expressed on hepatocytes, it might represent a portal of cellular entry for HBV infection. This system of antigen presentation by T cells may serve as a model to study both lymphocyte receptors used by lymphocytotropic viruses and viral proteins critical to bind them.
Similar articles
-
Soluble transferrin mediates targeting of hepatitis B envelope antigen to transferrin receptor and its presentation by activated T cells.Eur J Immunol. 1994 Jun;24(6):1372-6. doi: 10.1002/eji.1830240620. Eur J Immunol. 1994. PMID: 8206097
-
Antigen targeting to antigen-presenting cells enhances presentation to class II-restricted T lymphocytes.Immunology. 1994 Jan;81(1):167-70. Immunology. 1994. PMID: 7907575 Free PMC article.
-
Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes.Nature. 1990 May 17;345(6272):258-60. doi: 10.1038/345258a0. Nature. 1990. PMID: 2110296
-
Interactions of hepatitis B virus with hepatocytes: mechanism and clinical relevance.Hepatogastroenterology. 1991 Feb;38(1):10-3. Hepatogastroenterology. 1991. PMID: 1709133 Review.
-
Nature and display of hepatitis B virus envelope proteins and the humoral immune response.Springer Semin Immunopathol. 1990;12(1):5-23. doi: 10.1007/BF00192678. Springer Semin Immunopathol. 1990. PMID: 1695029 Review. No abstract available.
Cited by
-
Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.Clin Pharmacokinet. 1996 Aug;31(2):131-55. doi: 10.2165/00003088-199631020-00005. Clin Pharmacokinet. 1996. PMID: 8853935 Review.
-
Hepatitis B virus surface antigen binds to apolipoprotein H.J Virol. 1994 Apr;68(4):2415-24. doi: 10.1128/JVI.68.4.2415-2424.1994. J Virol. 1994. PMID: 8139027 Free PMC article.
-
Role of Immunological Cells in Hepatocellular Carcinoma Disease and Associated Pathways.ACS Pharmacol Transl Sci. 2023 Nov 8;6(12):1801-1816. doi: 10.1021/acsptsci.3c00216. eCollection 2023 Dec 8. ACS Pharmacol Transl Sci. 2023. PMID: 38093838 Free PMC article. Review.
-
Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection.J Clin Invest. 2004 Apr;113(7):963-72. doi: 10.1172/JCI20515. J Clin Invest. 2004. PMID: 15057302 Free PMC article.
-
Mycobacterial antigens induce apoptosis in human purified protein derivative-specific alphabeta T lymphocytes in a concentration-dependent manner.Immunology. 2002 Feb;105(2):222-30. doi: 10.1046/j.0019-2805.2001.01355.x. Immunology. 2002. PMID: 11872098 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials